Karen Knudsen to leave ACS

Brian Druker steps down as CEO of OHSU Knight Cancer Center

On Dec. 3, the faculty and staff members at the OHSU Knight Cancer Institute received an email from Brian J. Druker, the institution’s star scientist, former director, and current CEO, informing them that he would be stepping down from his executive role.

Michael Wong joins Roswell Park as physician-in-chief

Michael Wong joined Roswell Park Comprehensive Cancer Center as the center’s first physician-in-chief.

December 06, 2024

Vol.50 No.45

In Brief

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS

As the Trump administration stands poised to redraft the nation’s public health priorities, the American Cancer Society, one of the most prominent advocates for cancer patients, finds itself in an interregnum, following an abrupt departure of its Chief Executive Officer Karen E. Knudsen.

November 08, 2024

Vol.50 No.42

By Paul Goldberg

Conversation with The Cancer Letter

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

A curious piece of paper hangs in a frame outside the director’s office at University of Iowa Holden Comprehensive Cancer Center on the second floor of the General Hospital.

Medicaid expansion may improve cancer care and survival for people with HR-negative, HER2-positive breast cancer

New research published in the Journal of the National Comprehensive Cancer Network found that people with newly-diagnosed hormone receptor-negative, human epidermal growth factor receptor 2-positive breast cancer were more likely to receive timely, guideline-concordant treatment, and have longer survival in states that participate in Medicaid expansion under the Affordable Care Act.

October 25, 2024

Vol.50 No.40

YOU MAY BE INTERESTED IN

Brian Druker steps down as CEO of OHSU Knight Cancer Center

Michael Wong joins Roswell Park as physician-in-chief

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

Medicaid expansion may improve cancer care and survival for people with HR-negative, HER2-positive breast cancer

Renew today!

Subscriber content

Never miss an issue!

Login

Karen Knudsen to leave ACS

YOU MAY BE INTERESTED IN

Brian Druker steps down as CEO of OHSU Knight Cancer Center

Michael Wong joins Roswell Park as physician-in-chief

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinicsThe state has the second highest (and rising) cancer rates in the U.S.

Medicaid expansion may improve cancer care and survival for people with HR-negative, HER2-positive breast cancer

Never miss an issue!

Login

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.